日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation

达格列净通过调节 AKT 介导的氧化应激、心脏重塑和炎症减轻阿霉素引起的心肌损伤

Pei-Ling Hsieh, Pei-Ming Chu, Hui-Ching Cheng, Yu-Ting Huang, Wan-Ching Chou, Kun-Ling Tsai, Shih-Hung Chan

Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK

达格列净通过调节 AMPK 减轻缺氧/复氧引起的心脏功能障碍和氧化损伤

Kun-Ling Tsai #, Pei-Ling Hsieh #, Wan-Ching Chou, Hui-Ching Cheng, Yu-Ting Huang, Shih-Hung Chan

Low-level laser prevents doxorubicin-induced skeletal muscle atrophy by modulating AMPK/SIRT1/PCG-1α-mediated mitochondrial function, apoptosis and up-regulation of pro-inflammatory responses

低强度激光通过调节 AMPK/SIRT1/PCG-1α 介导的线粒体功能、细胞凋亡和促炎反应上调来预防阿霉素引起的骨骼肌萎缩

Hsiu-Chung Ou #, Pei-Ming Chu #, Yu-Ting Huang, Hui-Ching Cheng, Wan-Ching Chou, Hsin-Lun Yang, Hsiu-I Chen, Kun-Ling Tsai

Anti-IL-20 Antibody Protects against Ischemia/Reperfusion-Impaired Myocardial Function through Modulation of Oxidative Injuries, Inflammation and Cardiac Remodeling

抗 IL-20 抗体通过调节氧化损伤、炎症和心脏重塑来预防缺血/再灌注损伤的心肌功能

Kun-Ling Tsai, Wan-Ching Chou, Hui-Ching Cheng, Yu-Ting Huang, Ming-Shi Chang, Shih-Hung Chan

Ginsenoside Rg3 Attenuates TNF-α-Induced Damage in Chondrocytes through Regulating SIRT1-Mediated Anti-Apoptotic and Anti-Inflammatory Mechanisms

人参皂苷 Rg3 通过调节 SIRT1 介导的抗凋亡和抗炎机制减轻 TNF-α 诱导的软骨细胞损伤

Ching-Hou Ma, Wan-Ching Chou, Chin-Hsien Wu, I-Ming Jou, Yuan-Kun Tu, Pei-Ling Hsieh, Kun-Ling Tsai

Early Moderate Intensity Aerobic Exercise Intervention Prevents Doxorubicin-Caused Cardiac Dysfunction Through Inhibition of Cardiac Fibrosis and Inflammation

早期中强度有氧运动干预可通过抑制心脏纤维化和炎症来预防阿霉素引起的心脏功能障碍

Hsin-Lun Yang, Pei-Ling Hsieh, Ching-Hsia Hung, Hui-Ching Cheng, Wan-Ching Chou, Pei-Ming Chu, Yun-Ching Chang, Kun-Ling Tsai